A phase 1 trial of the MEK1/2 inhibitor AZD6244 in combination with thoracic radiotherapy in advanced non-small cell lung cancer (NSCLC).

PK Koh, R Califano, E Dean, Corinne Faivre-Finn, J Kosmin, O Ataman, A Jackson, Fiona Blackhall

Research output: Contribution to journal › Commentary/debate › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{d375a9cdba8340778c5aa5107677357d,

title = "A phase 1 trial of the MEK1/2 inhibitor AZD6244 in combination with thoracic radiotherapy in advanced non-small cell lung cancer (NSCLC).",

author = "PK Koh and R Califano and E Dean and Corinne Faivre-Finn and J Kosmin and O Ataman and A Jackson and Fiona Blackhall",

year = "2010",

month = jan,

language = "English",

volume = "67",

pages = "S33--S34",

journal = "Lung Cancer",

issn = "1872-8332",

publisher = "Elsevier BV",

number = "S1",

}

TY - JOUR

T1 - A phase 1 trial of the MEK1/2 inhibitor AZD6244 in combination with thoracic radiotherapy in advanced non-small cell lung cancer (NSCLC).

AU - Koh, PK

AU - Califano, R

AU - Dean, E

AU - Faivre-Finn, Corinne

AU - Kosmin, J

AU - Ataman, O

AU - Jackson, A

AU - Blackhall, Fiona

PY - 2010/1

Y1 - 2010/1

M3 - Commentary/debate

SN - 1872-8332

VL - 67

SP - S33-S34

JO - Lung Cancer

JF - Lung Cancer

IS - S1

ER -